RBR-34f2px4尚未招募未知

The impact of pharmaceutical care in the context of individualized-centered health care for the safety of pharmacotherapy in hospitalized elderly: a clinical trial

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP)0 个研究点开始时间: 2021年5月14日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Being 60 years old or more; being on one or more prescription drugs; have a source of confirmation of the drugs you routinely use, such as medical records or history of care in primary health care, or be aware to report this information, or even have a companion who holds this data about your treatment; to be admitted to the geriatric ward for at least 24 hours and, after this time has elapsed, not to be discharged from the hospital already scheduled; consent to participate in the study and sign, or the responsible person, the informed consent form

•Withdraw the consent to participate in the course of the research, due to the individual's will or the person responsible for it

发起方

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP)